BioWorld 2026년 5월 20일 Shanghai Institute of Materia Medica and Yantai New Drug Creation patent new DACs
Novo Nordisk 2026년 5월 20일 50-60% of Danish Wegovy patients do not reach the maximum dose - medwatch.com
Pfizer 2026년 5월 20일 Pfizer takes paediatric 25-valent pneumococcal vaccine to Phase III - FirstWord PHARMA
Edwards Lifesciences 2026년 5월 20일 Edwards Lifesciences stock (US28176E1082): Guidance and revenue growth stay in focus - AD HOC NEWS
Moderna 2026년 5월 20일 ROIV: Strong clinical progress and a $2.25B Moderna settlement drive robust financial position - TradingView
Endpoints News 2026년 5월 20일 Parabilis reveals IPO plans the day after Regeneron deal as listings heat up
Endpoints News 2026년 5월 20일 GHO Capital, CBC Group to merge, forming what could be the largest healthcare specialist investor
FierceBiotech 2026년 5월 20일 Parabilis, fresh from inking Regeneron pact, plans IPO to fund tumor drug’s phase 3 push
Recursion 2026년 5월 20일 Can Altitude Lab’s Early Wins Reframe Recursion Pharmaceuticals’ (RXRX) High-Burn Platform Bet? - simplywall.st
Bio-Rad 2026년 5월 20일 Bio Rad Laboratories Stock Surges 11% on Reports of Activist Elliott Investment Management Stake - TIKR.com
FierceBiotech 2026년 5월 20일 Pfizer furthers pneumococcal efforts, remains ‘comfortable’ taking on emerging threats: vaccine chief
Pfizer 2026년 5월 20일 Pfizer furthers pneumococcal efforts, remains ‘comfortable’ taking on emerging threats: vaccine chief - Fierce Biotech